The FASEB Journal · 2015 · 31 citations · 39 references
MedicineCardiologyCell BiologyCardiovascular GeneticsInflammationSignal TransductionEicosanoid BiosynthesisPlatelet ActivationPlatelet DisordersPlatelet FunctionPlatelet PhysiologyEnzymatic Regulation Of Eicosanoid SynthesisInherited Platelet Activation DisordersPhospholipase A2 PathwayPhospholipase A2-mediated ReleaseProstacyclin BiosynthesisProstaglandin E2 BiosynthesisProstaglandin ProductionThromboxane Biosynthesis
ABSTRACT Eicosanoids are important vascular regulators, but the phospholipase A 2 (PLA 2 ) isoforms supporting their production within the cardiovascular system are not fully understood. To address this, we have studied platelets, endothelial cells, and leukocytes from 2 siblings with a homozygous loss‐of‐function mutation in group IVA cytosolic phospholipase A 2 (cPLA 2 α). Chromatography/mass spectrometry was used to determine levels of a broad range of eicosanoids produced by isolated vascular cells, and in plasma and urine. Eicosanoid release data were paired with studies of cellular function. Absence of cPLA 2 α almost abolished eicosanoid synthesis in platelets ( e.g. , thromboxane A 2 , control 20.5 ±1.4 ng/ml vs. patient 0.1 ng/ml) and leukocytes [ e.g. , prostaglandin E 2 (PGE 2 ), control 21.9 ± 7.4 ng/ml vs. patient 1.9 ng/ml], and this was associated with impaired platelet activation and enhanced inflammatory responses. cPLA 2 α‐deficient endothelial cells showed reduced, but not absent, formation of prostaglandin I 2 (prostacyclin; control 956 ± 422 pg/ml vs. patient 196 pg/ml) and were primed for inflammation. In the urine, prostaglandin metabolites were selectively influenced by cPLA 2 α deficiency. For example, prostacyclin metabolites were strongly reduced (18.4% of control) in patients lacking cPLA 2 α, whereas PGE 2 metabolites (77.8% of control) were similar to healthy volunteer levels. These studies constitute a definitive account, demonstrating the fundamental role of cPLA 2 α to eicosanoid formation and cellular responses within the human circulation.—Kirkby, N. S., Reed, D. M., Edin, M. L., Rauzi, F., Mataragka, S., Vojnovic, I., Bishop‐Bailey, D., Milne, G. L., Longhurst, H., Zeldin, D. C., Mitchell, J. A., Warner, T. D. Inherited human group IVA cytosolic phospholipase A 2 deficiency abolishes platelet, endothelial, and leucocyte eicosanoid generation. FASEB J. 29, 4568‐4578 (2015). www.fasebj.org
39
Timothy D. Warner, Francesco Giuliano, Ivana Vojnovic et al. · Proceedings of the National Academy of Sciences · 1999 · 1.5K citations · Full text
Garret A. FitzGerald, John A. Oates, Jacek Hawiger et al. · Journal of Clinical Investigation · 1983 · 671 citations · Full text
Paola Patrignani, Maria R. Panara, Anita Greco et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 518 citations
Endothelial von Willebrand factor regulates angiogenesis
Richard Starke, Francesco Ferraro, Koralia Paschalaki et al. · Blood · 2010 · 497 citations · Full text